# Asian Myeloproliferative Neoplasm (MPN) Registry

> **NCT05882773** · — · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 1000 (estimated)

## Conditions studied

- Myeloproliferative Neoplasm
- Polycythemia Vera
- Essential Thrombocythemia
- Post-polycythemia Vera Myelofibrosis
- Post-essential Thrombocythemia Myelofibrosis
- Primary Myelofibrosis
- Primary Myelofibrosis, Prefibrotic Stage
- Primary Myelofibrosis, Fibrotic Stage

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05882773
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05
- **Primary completion:** 2026-05
- **Final completion:** 2026-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05882773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05882773, "Asian Myeloproliferative Neoplasm (MPN) Registry". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT05882773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
